咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Recent advances in cancer-asso... 收藏

Recent advances in cancer-associated fibroblast:Biomarkers,signaling pathways,and therapeutic opportunities

Recent advances in cancer-associated fibroblast: Biomarkers, signaling pathways, and therapeutic opportunities

作     者:Donger Zhou Lei Zheng 

作者机构:Department of Hepatobiliary-Pancreatic SurgeryThe Second Affiliated HospitalZhejiang University School of MedicineHangzhouZhejiang 310009China Sidney Kimmel Comprehensive Cancer CenterThe Skip Viragh Pancreatic Cancer Center for Clinical Research and Careand The Bloomberg-Kimmel Institute for Immunotherapy at Johns Hopkins University School of MedicineBaltimoreMD 21287USA 

出 版 物:《Chinese Medical Journal》 (中华医学杂志(英文版))

年 卷 期:2024年第137卷第6期

页      面:638-650页

核心收录:

学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

基  金:supported by grants from the Natural Science Foundation of Zhejiang Province,China(No.LQ15H160010) the National Science Foundation of China(No.81702382). 

主  题:Cancer-associated fibroblasts Tumor microenvironment Anti-cancer therapy Targeted therapy 

摘      要:Anti-cancer therapies usually focus on tumor cells,but non-tumor stromal components in the tumor microenvironment also play vital roles in tumor initiation and progression,which may be the prognostic factors and potential therapeutic targets.Cancer-associated fibroblasts(CAFs)are the essential component in the tumor environment,exhibiting high heterogeneity in their cell origin and phenotype with diverse functions that influence tumor angiogenesis,immune systems,and metabolism.Single-cell RNA sequencing and genetically engineered mouse models have increased our understanding of CAF diversity,and many subtypes have been defined.However,the precise functions of these subtypes need to be studied and validated.Studies of signaling pathways and epigenetic changes in CAFs facilitate understanding of the phenotypes of CAFs and the crosstalk between tumor cells and CAFs to provide potential therapeutic targets.Some clinical trials,including phase III trials targeting CAFs,have been performed recently.However,few of these trials have generated promising results,which indicates that the complexity of CAFs in the tumor microenvironment remains largely unknown,and in-depth investigations of CAFs should be performed.This review summarizes the research on CAFs,focusing on the heterogeneity of their phenotypes and functions,specific signaling pathways,and the therapeutic strategies involving CAFs.Additionally,we briefly discuss the current technologies commonly used in CAF studies and describe the challenges and future perspectives of CAF research.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分